114 related articles for article (PubMed ID: 37325865)
1. Identification of a seven autophagy-related gene pairs signature for the diagnosis of colorectal cancer using the RankComp algorithm.
Song QS; Wu HJ; Lin Q; Tang YK
J Bioinform Comput Biol; 2023 Jun; 21(3):2350012. PubMed ID: 37325865
[TBL] [Abstract][Full Text] [Related]
2. Differential expression analysis for individual cancer samples based on robust within-sample relative gene expression orderings across multiple profiling platforms.
Guan Q; Chen R; Yan H; Cai H; Guo Y; Li M; Li X; Tong M; Ao L; Li H; Hong G; Guo Z
Oncotarget; 2016 Oct; 7(42):68909-68920. PubMed ID: 27634898
[TBL] [Abstract][Full Text] [Related]
3. Quantitative or qualitative transcriptional diagnostic signatures? A case study for colorectal cancer.
Guan Q; Yan H; Chen Y; Zheng B; Cai H; He J; Song K; Guo Y; Ao L; Liu H; Zhao W; Wang X; Guo Z
BMC Genomics; 2018 Jan; 19(1):99. PubMed ID: 29378509
[TBL] [Abstract][Full Text] [Related]
4. Identifying CpG sites with different differential methylation frequencies in colorectal cancer tissues based on individualized differential methylation analysis.
Yan H; He J; Guan Q; Cai H; Zhang L; Zheng W; Qi L; Zhang S; Liu H; Li H; Zhao W; Yang S; Guo Z
Oncotarget; 2017 Jul; 8(29):47356-47364. PubMed ID: 28537885
[TBL] [Abstract][Full Text] [Related]
5. Circumvent the uncertainty in the applications of transcriptional signatures to tumor tissues sampled from different tumor sites.
Cheng J; Guo Y; Gao Q; Li H; Yan H; Li M; Cai H; Zheng W; Li X; Jiang W; Guo Z
Oncotarget; 2017 May; 8(18):30265-30275. PubMed ID: 28427173
[TBL] [Abstract][Full Text] [Related]
6. Identifying primary site of lung-limited Cancer of unknown primary based on relative gene expression orderings.
Li M; Li H; Hong G; Tang Z; Liu G; Lin X; Lin M; Qi L; Guo Z
BMC Cancer; 2019 Jan; 19(1):67. PubMed ID: 30642283
[TBL] [Abstract][Full Text] [Related]
7. A qualitative transcriptional signature for the early diagnosis of colorectal cancer.
Guan Q; Zeng Q; Yan H; Xie J; Cheng J; Ao L; He J; Zhao W; Chen K; Guo Y; Guan G; Guo Z
Cancer Sci; 2019 Oct; 110(10):3225-3234. PubMed ID: 31335996
[TBL] [Abstract][Full Text] [Related]
8. The prognostic and clinical significance of IFI44L aberrant downregulation in patients with oral squamous cell carcinoma.
Ou D; Wu Y
BMC Cancer; 2021 Dec; 21(1):1327. PubMed ID: 34903206
[TBL] [Abstract][Full Text] [Related]
9. Two novel qualitative transcriptional signatures robustly applicable to non-research-oriented colorectal cancer samples with low-quality RNA.
Cheng J; Guo Y; Guan G; Huang H; Jiang F; He J; Wu J; Guo Z; Liu X; Ao L
J Cell Mol Med; 2021 Apr; 25(7):3622-3633. PubMed ID: 33719152
[TBL] [Abstract][Full Text] [Related]
10. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
[TBL] [Abstract][Full Text] [Related]
11. A qualitative transcriptional signature for predicting microsatellite instability status of right-sided Colon Cancer.
Fu Y; Qi L; Guo W; Jin L; Song K; You T; Zhang S; Gu Y; Zhao W; Guo Z
BMC Genomics; 2019 Oct; 20(1):769. PubMed ID: 31646964
[TBL] [Abstract][Full Text] [Related]
12. Identification of a Novel Five-Gene Signature as a Prognostic and Diagnostic Biomarker in Colorectal Cancers.
Ghatak S; Mehrabi SF; Mehdawi LM; Satapathy SR; Sjölander A
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054980
[TBL] [Abstract][Full Text] [Related]
13. A qualitative transcriptional signature to reclassify histological grade of ER-positive breast cancer patients.
Li J; Jiang W; Liang Q; Liu G; Dai Y; Zheng H; Yang J; Cai H; Zheng G
BMC Genomics; 2020 Apr; 21(1):283. PubMed ID: 32252627
[TBL] [Abstract][Full Text] [Related]
14. Identification of genes with universally upregulated or downregulated expressions in colorectal cancer.
Song K; Su W; Liu Y; Zhang J; Liang Q; Li N; Guan Q; He J; Bai X; Zhao W; Guo Z
J Gastroenterol Hepatol; 2019 May; 34(5):880-889. PubMed ID: 30395690
[TBL] [Abstract][Full Text] [Related]
15. A qualitative transcriptional signature for determining the grade of colorectal adenocarcinoma.
Zheng H; Song K; Fu Y; You T; Yang J; Guo W; Wang K; Jin L; Gu Y; Qi L; Zhao W; Guo Z
Cancer Gene Ther; 2020 Sep; 27(9):680-690. PubMed ID: 31595030
[TBL] [Abstract][Full Text] [Related]
16. A robust genomic signature for the detection of colorectal cancer patients with microsatellite instability phenotype and high mutation frequency.
Tian S; Roepman P; Popovici V; Michaut M; Majewski I; Salazar R; Santos C; Rosenberg R; Nitsche U; Mesker WE; Bruin S; Tejpar S; Delorenzi M; Bernards R; Simon I
J Pathol; 2012 Dec; 228(4):586-95. PubMed ID: 22926706
[TBL] [Abstract][Full Text] [Related]
17. A Qualitative Transcriptional Signature for Predicting Prognosis and Response to Bevacizumab in Metastatic Colorectal Cancer.
Yang J; Song K; Guo W; Zheng H; Fu Y; You T; Wang K; Qi L; Zhao W; Guo Z
Mol Cancer Ther; 2020 Jul; 19(7):1497-1505. PubMed ID: 32371582
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional signatures for coupled predictions of stage II and III colorectal cancer metastasis and fluorouracil-based adjuvant chemotherapy benefit.
Song K; Guo Y; Wang X; Cai H; Zheng W; Li N; Song X; Ao L; Guo Z; Zhao W
FASEB J; 2019 Jan; 33(1):151-162. PubMed ID: 29957060
[TBL] [Abstract][Full Text] [Related]
19. Gene Selection for the Discrimination of Colorectal Cancer.
Wang W; Xie G; Ren Z; Xie T; Li J
Curr Mol Med; 2020; 20(6):415-428. PubMed ID: 31746296
[TBL] [Abstract][Full Text] [Related]
20. Gene pair based prognostic signature for colorectal colon cancer.
Shu P; Wu J; Tong Y; Xu C; Zhang X
Medicine (Baltimore); 2018 Oct; 97(42):e12788. PubMed ID: 30334969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
